STEPHANIE CANIPE: Open Payments
NPI 1871133850 · HAVELOCK, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 24 payments from 7 companies in 2025. Trend: 2023 $48 · 2024 $354 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $97 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| GlaxoSmithKline, LLC. | 5 | $90 |
| ABBVIE INC. | 3 | $58 |
| Amgen Inc. | 3 | $44 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| PFIZER INC. | 1 | $19 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, OTEZLA, VRAYLAR, Rybelsus, Wegovy, HETLIOZ, FARXIGA.
Industry payments across NC — which companies pay providers there.
